Literature DB >> 17210937

Cost of cancer care: issues and implications.

Neal J Meropol1, Kevin A Schulman.   

Abstract

Medical technology is increasingly costly in most fields of clinical medicine. Oncology has not been spared from issues related to cost, in part resulting from the tremendous scientific progress that has lead to new tools for diagnosis, treatment, and follow-up of our patients. The increasing cost of health care in general (and cancer care in particular) raises complex questions related to its effects on our economy and the citizens of our society. This article reviews the macroeconomic principles and individual behaviors that govern medical spending, and examines how cost disproportionately affects various populations. Our overall goal is to frame debate about health policy concerns that influence the clinical practice of oncology.

Entities:  

Mesh:

Year:  2007        PMID: 17210937     DOI: 10.1200/JCO.2006.09.6081

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  101 in total

Review 1.  A way forward on the medically appropriate use of white cell growth factors.

Authors:  Thomas J Smith; Bruce E Hillner
Journal:  J Clin Oncol       Date:  2012-02-27       Impact factor: 44.544

2.  The cost-effectiveness of screening for colorectal cancer.

Authors:  Jennifer J Telford; Adrian R Levy; Jennifer C Sambrook; Denise Zou; Robert A Enns
Journal:  CMAJ       Date:  2010-07-12       Impact factor: 8.262

3.  Multiple Stakeholder Perspectives on Cancer Stigma in North India.

Authors:  Adyya Gupta; Preet K Dhillon; Jyotsna Govil; Dipika Bumb; Subhojit Dey; Suneeta Krishnan
Journal:  Asian Pac J Cancer Prev       Date:  2015

4.  The future workforce in cancer prevention: advancing discovery, research, and technology.

Authors:  Wayne D Newhauser; Michael E Scheurer; Jessica M Faupel-Badger; Jessica Clague; Jeffrey Weitzel; Kendra V Woods
Journal:  J Cancer Educ       Date:  2012-05       Impact factor: 2.037

5.  Therapy of colon carcinoma: an oncology perspective. Interview with Piotr M. Czaykowski by Paul C. Adams.

Authors:  Piotr M Czaykowski
Journal:  Can J Gastroenterol       Date:  2007-08       Impact factor: 3.522

6.  The imperative to address the cost of oncology care.

Authors:  Neal J Meropol
Journal:  J Natl Cancer Inst       Date:  2013-11-13       Impact factor: 13.506

7.  Radiofrequency ablation plus nucleotide analogous for hepatitis B virus-related hepatocellular carcinoma: a cost-effectiveness analysis.

Authors:  Baoxian Liu; Mengchao Wei; Furong Liu; Shuling Chen; Zhenwei Peng; Bin Li; Qian Zhou; Haibo Wang; Sui Peng; Ming Kuang
Journal:  Am J Transl Res       Date:  2018-08-15       Impact factor: 4.060

8.  Comparative economic evaluation of data from the ACRIN National CT Colonography Trial with three cancer intervention and surveillance modeling network microsimulations.

Authors:  David J Vanness; Amy B Knudsen; Iris Lansdorp-Vogelaar; Carolyn M Rutter; Ilana F Gareen; Benjamin A Herman; Karen M Kuntz; Ann G Zauber; Marjolein van Ballegooijen; Eric J Feuer; Mei-Hsiu Chen; C Daniel Johnson
Journal:  Radiology       Date:  2011-08-03       Impact factor: 11.105

Review 9.  Electronic medical records and quality of cancer care.

Authors:  Thomas R Klumpp
Journal:  Curr Oncol Rep       Date:  2013-12       Impact factor: 5.075

Review 10.  When is cancer care cost-effective? A systematic overview of cost-utility analyses in oncology.

Authors:  Dan Greenberg; Craig Earle; Chi-Hui Fang; Adi Eldar-Lissai; Peter J Neumann
Journal:  J Natl Cancer Inst       Date:  2010-01-07       Impact factor: 13.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.